Breast cancer, colorectal cancer, lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Malignant tumor group: Inclusion criteria: - Men and women aged from 30 to 80 years old; - The examination results within the last six months met the diagnostic criteria for malignant tumors as specified in this study 2. Benign disease or healthy group: Inclusion criteria: - Men and women aged from 30 to 80 years old; - Examination results within the last six months met the diagnostic criteria for benign disease or health as specified in this study
Exclusion criteria
Exclusion criteria: 1. Malignant tumor group: Exclusion criteria: -Patients with previous findings suggestive of immune disorders due to other causes. -Diagnosed as malignant tumor before or during hospitalization -Patients with more than two tumors -Patients who have received allogeneic blood transfusion or cell therapy within 1 year. -Pregnant females. 2. Benign disease or healthy group: Exclusion criteria: - Patients with previous findings suggestive of immune disorders due to other causes. - Patients who have received allogeneic blood transfusion or cell therapy within 1 year. - Pregnant females.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DNA methylation sites; | — |
Countries
China
Contacts
The Second Hospital of Shandong University